Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review
2021-01-01 Trapani, D; Giugliano, F; Uliano, J; Zia, V A A; Marra, A; Viale, G; Ferraro, E; Esposito, A; Criscitiello, C; D'Amico, P; Curigliano, G
Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
2020-01-01 Diana, Anna; Carlino, Francesca; Franzese, Elisena; Oikonomidou, Olga; Criscitiello, Carmen; De Vita, Ferdinando; Ciardiello, Fortunato; Orditura, Michele
Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers
2018-01-01 Criscitiello, Carmen; Santangelo, Michele; Loupakis, Fotios
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
2014-01-01 Salgado, R; Denkert, C; Demaria, S; Sirtaine, N; Klauschen, F; Pruneri, G; Wienert, S; Van Den Eynden, G; Baehner, Fl; Penault-Llorca, F; Perez, Ea; Thompson, Ea; Symmans, Wf; Richardson, Al; Brock, J; Criscitiello, C; Bailey, H; Ignatiadis, M; Floris, G; Sparano, J; Kos, Z; Nielsen, T; Rimm, Dl; Allison, Kh; Reis-Filho, Js; Loibl, S; Sotiriou, C; Viale, G; Badve, S; Adams, S; Willard-Gallo, K; Loi, S; International Tils Working Group, 2014
Cardiotoxicity of systemic agents used in breast cancer
2014-01-01 Ades, F; Zardavas, D; Pinto, Ac; Criscitiello, C; Aftimos, P; De Azambuja, E
Future potential targets of antibody-drug conjugates in breast cancer
2023-01-01 Corti, Chiara; Boscolo Bielo, Luca; Schianca, Ambra Carnevale; Salimbeni, Beatrice Taurelli; Criscitiello, Carmen; Curigliano, Giuseppe
Dendritic cell-based vaccines : clinical applications in breast cancer
2014-01-01 Gelao, L.; Criscitiello, C.; Esposito, A.; Laurentiis, M. D.; Fumagalli, L.; Locatelli, M. A.; Minchella, I.; Santangelo, M.; Placido, S. D.; Goldhirsch, A.; Giuseppe, Curigliano
Mechanism of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist
2015-01-01 Esposito, A.; Criscitiello, C.; Gelao, L.; Pravettoni, G.; Locatelli, M.; Minchella, I.; Di Leo, M.; Liuzzi, R.; Milani, A.; Massaro, M.; Curigliano, G.
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
2022-01-01 Venetis, K.; Crimini, E.; Sajjadi, E.; Corti, C.; Guerini-Rocco, E.; Viale, G.; Curigliano, G.; Criscitiello, C.; Fusco, N.
Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast Cancer
2021-01-01 Criscitiello, Carmen; Spurden, Dean; Piercy, James; Rider, Alex; Williams, Rhys; Mitra, Debanjali; Wild, Rosie; Corsaro, Massimo; Kurosky, Samantha K; Law, Ernest H
A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer
2019-01-01 Esposito, Angela; Viale, Giulia; Criscitiello, Carmen; Curigliano, Giuseppe
The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility
2023-01-01 Antonarelli, Gabriele; Taurelli Salimbeni, Beatrice; Marra, Antonio; Esposito, Angela; Locatelli, Marzia Adelia; Trapani, Dario; Pescia, Carlo; Fusco, Nicola; Curigliano, Giuseppe; Criscitiello, Carmen
Circulating tumor cells and emerging blood biomarkers in breast cancer
2010-01-01 Criscitiello, C; Sotiriou, C; Ignatiadis, M
Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials
2021-01-01 Criscitiello, Carmen; Marra, Antonio; Morganti, Stefania; Zagami, Paola; Gandini, Sara; Esposito, Angela; Curigliano, Giuseppe
Barriers to the use of trastuzumab for HER2+ breast cancer and the potential impact of biosimilars : a physician survey in the united states and emerging markets
2014-01-01 Lammers, P.; Criscitiello, C.; Curigliano, G.; Jacobs, I.
Adjuvant treatment of early male breast cancer
2020-01-01 Corti, C.; Crimini, E.; Criscitiello, C.; Trapani, D.; Curigliano, G.
Targeting brain metastases in breast cancer
2022-01-01 Corti, C.; Antonarelli, G.; Criscitiello, C.; Lin, N. U.; Carey, L. A.; Cortes, J.; Poortmans, P.; Curigliano, G.
HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence
2016-01-01 Criscitiello, Carmen; Bagnardi, Vincenzo; Viale, Giuseppe; Disalvatore, Davide; Rotmensz, Nicole; Esposito, Angela; Goldhirsch, Aron; Curigliano, Giuseppe
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents
2023-01-01 Nicolò, Eleonora; Tarantino, Paolo; D'Ecclesiis, Oriana; Antonarelli, Gabriele; Boscolo Bielo, Luca; Marra, Antonio; Gandini, Sara; Crimini, Edoardo; Giugliano, Federica; Zagami, Paola; Corti, Chiara; Trapani, Dario; Morganti, Stefania; Criscitiello, Carmen; Locatelli, Marzia; Belli, Carmen; Esposito, Angela; Minchella, Ida; Cristofanilli, Massimo; Tolaney, Sara M; Curigliano, Giuseppe
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial
2024-01-01 Migliaccio, Ilenia; Romagnoli, Dario; Galardi, Francesca; De Luca, Francesca; Biagioni, Chiara; Curigliano, Giuseppe; Criscitiello, Carmen; Minisini, Alessandro Marco; Moretti, Erica; Risi, Emanuela; Guarducci, Cristina; Nardone, Agostina; Biganzoli, Laura; Benelli, Matteo; Malorni, Luca
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review | 1-gen-2021 | Trapani, D; Giugliano, F; Uliano, J; Zia, V A A; Marra, A; Viale, G; Ferraro, E; Esposito, A; Criscitiello, C; D'Amico, P; Curigliano, G | |
| Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes | 1-gen-2020 | Diana, Anna; Carlino, Francesca; Franzese, Elisena; Oikonomidou, Olga; Criscitiello, Carmen; De Vita, Ferdinando; Ciardiello, Fortunato; Orditura, Michele | |
| Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers | 1-gen-2018 | Criscitiello, Carmen; Santangelo, Michele; Loupakis, Fotios | |
| The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 | 1-gen-2014 | Salgado, R; Denkert, C; Demaria, S; Sirtaine, N; Klauschen, F; Pruneri, G; Wienert, S; Van Den Eynden, G; Baehner, Fl; Penault-Llorca, F; Perez, Ea; Thompson, Ea; Symmans, Wf; Richardson, Al; Brock, J; Criscitiello, C; Bailey, H; Ignatiadis, M; Floris, G; Sparano, J; Kos, Z; Nielsen, T; Rimm, Dl; Allison, Kh; Reis-Filho, Js; Loibl, S; Sotiriou, C; Viale, G; Badve, S; Adams, S; Willard-Gallo, K; Loi, S; International Tils Working Group, 2014 | |
| Cardiotoxicity of systemic agents used in breast cancer | 1-gen-2014 | Ades, F; Zardavas, D; Pinto, Ac; Criscitiello, C; Aftimos, P; De Azambuja, E | |
| Future potential targets of antibody-drug conjugates in breast cancer | 1-gen-2023 | Corti, Chiara; Boscolo Bielo, Luca; Schianca, Ambra Carnevale; Salimbeni, Beatrice Taurelli; Criscitiello, Carmen; Curigliano, Giuseppe | |
| Dendritic cell-based vaccines : clinical applications in breast cancer | 1-gen-2014 | Gelao, L.; Criscitiello, C.; Esposito, A.; Laurentiis, M. D.; Fumagalli, L.; Locatelli, M. A.; Minchella, I.; Santangelo, M.; Placido, S. D.; Goldhirsch, A.; Giuseppe, Curigliano | |
| Mechanism of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist | 1-gen-2015 | Esposito, A.; Criscitiello, C.; Gelao, L.; Pravettoni, G.; Locatelli, M.; Minchella, I.; Di Leo, M.; Liuzzi, R.; Milani, A.; Massaro, M.; Curigliano, G. | |
| HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer | 1-gen-2022 | Venetis, K.; Crimini, E.; Sajjadi, E.; Corti, C.; Guerini-Rocco, E.; Viale, G.; Curigliano, G.; Criscitiello, C.; Fusco, N. | |
| Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast Cancer | 1-gen-2021 | Criscitiello, Carmen; Spurden, Dean; Piercy, James; Rider, Alex; Williams, Rhys; Mitra, Debanjali; Wild, Rosie; Corsaro, Massimo; Kurosky, Samantha K; Law, Ernest H | |
| A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer | 1-gen-2019 | Esposito, Angela; Viale, Giulia; Criscitiello, Carmen; Curigliano, Giuseppe | |
| The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility | 1-gen-2023 | Antonarelli, Gabriele; Taurelli Salimbeni, Beatrice; Marra, Antonio; Esposito, Angela; Locatelli, Marzia Adelia; Trapani, Dario; Pescia, Carlo; Fusco, Nicola; Curigliano, Giuseppe; Criscitiello, Carmen | |
| Circulating tumor cells and emerging blood biomarkers in breast cancer | 1-gen-2010 | Criscitiello, C; Sotiriou, C; Ignatiadis, M | |
| Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials | 1-gen-2021 | Criscitiello, Carmen; Marra, Antonio; Morganti, Stefania; Zagami, Paola; Gandini, Sara; Esposito, Angela; Curigliano, Giuseppe | |
| Barriers to the use of trastuzumab for HER2+ breast cancer and the potential impact of biosimilars : a physician survey in the united states and emerging markets | 1-gen-2014 | Lammers, P.; Criscitiello, C.; Curigliano, G.; Jacobs, I. | |
| Adjuvant treatment of early male breast cancer | 1-gen-2020 | Corti, C.; Crimini, E.; Criscitiello, C.; Trapani, D.; Curigliano, G. | |
| Targeting brain metastases in breast cancer | 1-gen-2022 | Corti, C.; Antonarelli, G.; Criscitiello, C.; Lin, N. U.; Carey, L. A.; Cortes, J.; Poortmans, P.; Curigliano, G. | |
| HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence | 1-gen-2016 | Criscitiello, Carmen; Bagnardi, Vincenzo; Viale, Giuseppe; Disalvatore, Davide; Rotmensz, Nicole; Esposito, Angela; Goldhirsch, Aron; Curigliano, Giuseppe | |
| Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents | 1-gen-2023 | Nicolò, Eleonora; Tarantino, Paolo; D'Ecclesiis, Oriana; Antonarelli, Gabriele; Boscolo Bielo, Luca; Marra, Antonio; Gandini, Sara; Crimini, Edoardo; Giugliano, Federica; Zagami, Paola; Corti, Chiara; Trapani, Dario; Morganti, Stefania; Criscitiello, Carmen; Locatelli, Marzia; Belli, Carmen; Esposito, Angela; Minchella, Ida; Cristofanilli, Massimo; Tolaney, Sara M; Curigliano, Giuseppe | |
| Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial | 1-gen-2024 | Migliaccio, Ilenia; Romagnoli, Dario; Galardi, Francesca; De Luca, Francesca; Biagioni, Chiara; Curigliano, Giuseppe; Criscitiello, Carmen; Minisini, Alessandro Marco; Moretti, Erica; Risi, Emanuela; Guarducci, Cristina; Nardone, Agostina; Biganzoli, Laura; Benelli, Matteo; Malorni, Luca |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26842
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269046
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS226
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE181
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19414
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19124
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24589
- reserved1362
- open891